The results showed that CMTM6 and PD-L1 expression in TCs or ICs was not related to the prognosis of CRC patients, but CRC patients with high densities of CD4+ and CD8+ lymphocytes had a better prognosis (P < 0.001 and P = 0.005). This evidence concerns the gene CD8A and colorectal carcinoma.